中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
26期
88-90,91
,共4页
围绝经期子宫出血%中药%妈富隆%疗效
圍絕經期子宮齣血%中藥%媽富隆%療效
위절경기자궁출혈%중약%마부륭%료효
Perimenopausal uterine bleeding%Traditional Chinese Medicine%Marvelon%Efficacy
目的：探讨联合应用中药和妈富隆治疗围绝经期子宫出血的临床疗效。方法：选取本院2012年1月-2014年1月收治的60例围绝经期子宫出血患者，按照随机数字表法将其分为观察组和对照组各30例，对照组采取单用妈富隆治疗，观察组采取妈富隆联合中药汤剂益气固本止血汤治疗，观察比较两组患者治疗前后子宫内膜厚度、血红蛋白值改善情况、3种性激素指标及临床疗效的差异。结果：与治疗前比较，两组治疗后的子宫内膜厚度均明显缩小，血红蛋白值均明显升高，卵泡生成激素（FSH）、雌二醇（E2）、孕酮（P）水平均明显降低，而观察组上述观察指标均明显优于对照组，且观察组的治疗总有效率96.7%明显高于对照组的73.3%，差异均有统计学意义（P<0.05）。两组患者治疗期间均未见明显不良反应。结论：中药联合妈富隆治疗围绝经期子宫出血可明显提高疗效，不良反应少，值得临床推广。
目的：探討聯閤應用中藥和媽富隆治療圍絕經期子宮齣血的臨床療效。方法：選取本院2012年1月-2014年1月收治的60例圍絕經期子宮齣血患者，按照隨機數字錶法將其分為觀察組和對照組各30例，對照組採取單用媽富隆治療，觀察組採取媽富隆聯閤中藥湯劑益氣固本止血湯治療，觀察比較兩組患者治療前後子宮內膜厚度、血紅蛋白值改善情況、3種性激素指標及臨床療效的差異。結果：與治療前比較，兩組治療後的子宮內膜厚度均明顯縮小，血紅蛋白值均明顯升高，卵泡生成激素（FSH）、雌二醇（E2）、孕酮（P）水平均明顯降低，而觀察組上述觀察指標均明顯優于對照組，且觀察組的治療總有效率96.7%明顯高于對照組的73.3%，差異均有統計學意義（P<0.05）。兩組患者治療期間均未見明顯不良反應。結論：中藥聯閤媽富隆治療圍絕經期子宮齣血可明顯提高療效，不良反應少，值得臨床推廣。
목적：탐토연합응용중약화마부륭치료위절경기자궁출혈적림상료효。방법：선취본원2012년1월-2014년1월수치적60례위절경기자궁출혈환자，안조수궤수자표법장기분위관찰조화대조조각30례，대조조채취단용마부륭치료，관찰조채취마부륭연합중약탕제익기고본지혈탕치료，관찰비교량조환자치료전후자궁내막후도、혈홍단백치개선정황、3충성격소지표급림상료효적차이。결과：여치료전비교，량조치료후적자궁내막후도균명현축소，혈홍단백치균명현승고，란포생성격소（FSH）、자이순（E2）、잉동（P）수평균명현강저，이관찰조상술관찰지표균명현우우대조조，차관찰조적치료총유효솔96.7%명현고우대조조적73.3%，차이균유통계학의의（P<0.05）。량조환자치료기간균미견명현불량반응。결론：중약연합마부륭치료위절경기자궁출혈가명현제고료효，불량반응소，치득림상추엄。
Objective:To investigate the clinical effect of the combined use of TCM and Marvelon in treatment of perimenopausal uterine bleeding.Method:60 patients with perimenopausal uterine bleeding in our hospital from January 2012 to January 2014 were selected,they were divided into the control group and the observation group according to the random number table method,30 cases in each group.The control group was only treated with Marvelon,the observation group was treated with Marvelon combined Yiqi Guben decoction.The endometrial thickness,improvement of hemoglobin values,3 kinds of sex hormone indexes and clinical effect of the two groups before and after treatment were observed and compared.Result:Compared with before treatment,the endometrial thickness of two groups after treatment was significantly reduced,the hemoglobin values was significantly increased,hormone follicle stimulating hormone(FSH), estradiol(E2)and progesterone(P)levels were significantly decreased,the observed indexes of observation group were significantly better than the control group,total effective rate of the observation group was 96.7%,it was significantly higher than 73.3%of control group,the differences were statistically significant(P<0.05).The two groups during the treatment were no obvious adverse reactions.Conclusion:TCM combined with Marvelon in treatment of perimenopausal uterine bleeding can significantly improve the efficacy,fewer adverse reactions,is worthy of clinical promotion.
